Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers: WO2010066840.
about
Fluorescent system based on bacterial expression of hybrid KcsA channels designed for Kv1.3 ligand screening and study.Novel Kv1.3 blockers for immunosuppression: WO2012155199.Potassium channels: structures, diseases, and modulators.The voltage-gated potassium channel Kv1.3 is a promising multitherapeutic target against human pathologies.Immunosuppressive evidence of Tityus serrulatus toxins Ts6 and Ts15: insights of a novel K(+) channel pattern in T cells.
P2860
Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers: WO2010066840.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers: WO2010066840.
@en
type
label
Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers: WO2010066840.
@en
prefLabel
Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers: WO2010066840.
@en
P2860
P1476
Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers: WO2010066840.
@en
P2093
Heike Wulff
P2860
P304
P356
10.1517/13543776.2010.528392
P407
P577
2010-10-18T00:00:00Z